Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Roussey is active.

Publication


Featured researches published by M. Roussey.


Human Genetics | 1995

Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses

C. Férec; C. Verlingue; P. Parent; J. F. Morin; J.P. Codet; G. Rault; M. Dagorne; A. Lemoigne; Hubert Journel; M. Roussey; B. Le Marec; M. Catheline; M. P. Audrézet; B. Mercier

We have evaluated a two-tier neonatal cystic fibrosis (CF) screening of immunoreactive trypsinogen (IRT) followed by CFTR gene mutation analysis using a systematic scanning of exons 7, 10, and 11, and, if necessary, by direct DNA sequencing. Over an 18-month period we screened 32,300 neonates born in the western part of Britanny. The first tier, involving IRT screening at 3 days of age, utilizes a low elevation of the trypsinogen level (600 ng/ml), which is highly sensitive. The second tier, which corresponds to the exhaustive screening for mutations in three exons of the gene, is highly specific for this population (Britanny). The false positive rate is very low, and no false negatives have been reported to date. This strategy has allowed the identification of five novel alleles (V322A, V317A, 1806 del A, R553G, G544S). Moreover the test can be adapted to other countries in which the distribution of mutations is established.


Archives De Pediatrie | 2014

SFP CO-46 - Protection de l’enfance : connaissance et place des médecins généralistes (MG)

A. Amalia; M. Balençon; J.M. Berlinguer; J.-F. Brun; S. Cantero; A. Lefevre; M. Federico-Desgranges; M. Pierre; F. Tattevin; P. Pladys; M. Roussey

Objectif Evaluer l’etat des connaissances et des pratiques des MG concernant la realisation et la transmission d’une information preoccupante (IP) dans un contexte d’enfant en danger. Methode enquete epidemiologique descriptive en janvier 2013 aupres de l’ensemble des MG liberaux d’Ille-et-Vilaine. Resultats 33,5% (298/899) des MG ont repondu. L’echantillon etait comparable a la population des MG du departement. Seul 25.5% des MG avait entendu parler des dispositions legislatives du 5 mars 2007. Le terme d’IP etait inconnu de 70.1% des MG et son destinataire de 77.2% d’entre eux. La difference entre signalement judiciaire et IP etait ignoree par 79.5% des MG. L’obstacle principal a la transmission d’IP et a la collaboration avec les instances departementales etait le manque de formation (59.1%). Les 5% de MG de l’echantillon formes a l’IP etaient confrontes plus souvent a des situations de danger (86,7% vs 50,17%, p Conclusions Les dispositions legislatives actuelles qui concernent l’enfant en danger sont mal connues des MG de notre departement. La formation initiale et continue des MG ainsi que la realisation d’un guide sur l’IP sont des pistes de travail.


Archive | 1987

The Effectiveness of Chemotherapy in a Case of Childhood Esthesioneuroblastoma

E. Le Gall; M. Roussey; I. Casadevall; H. Jouan; M. Ben-Hassel; G. Le Clech; M. Carsin; C. Le François

Esthesioneuroblastoma or olfactory neuroblastoma is a rare tumour of neuronal origin (14) arising in the olfactory epithelium of the nasal vault. It is more frequently encountered in adults. Conventional treatment, consisting of surgical resection and/or radiation therapy, does not prevent local recurrence. The prognosis in cases of extensive disease is worse than in those of limited disease (5, 10). Good results in childhood neuroblastomas have been obtained with chemotherapy (7, 8). Various trials have therefore been proposed for certain olfactory neuroblastomas. The promising results encouraged us to use chemotherapy as the treatment of choice in a child of 4 suffering from an advanced form of the disease, given the consequences of surgery of radiotherapy at that age.


European Radiology | 2013

Whole-body post-mortem computed tomography compared with autopsy in the investigation of unexpected death in infants and children

Maia Proisy; Antoine Jérôme Marchand; Philippe Loget; R. Bouvet; M. Roussey; Fabienne Pelé; Céline Rozel; C. Treguier; Pierre Darnault; Bertrand Bruneau


Human Reproduction | 1995

Genetics: Obstructive azoospermia with agenesis of vas deferens or with bronchiectasia (Young's syndrome): a genetic approach

D. Le Lannou; Pascal Jézéquel; Martine Blayau; I. Dorval; P. Lemoine; A. Dabadie; M. Roussey; B.Le Marec; J.Y. Legall


Prenatal Diagnosis | 1986

Prenatal diagnosis of familial tuberous sclerosis following detection of cardiac rhabdomyoma by ultrasound

Hubert Journel; M. Roussey; M. H. Plais; J. Milon; C. Almange; B. Le Marec


American Journal of Medical Genetics | 1989

MCA/MR syndrome with oligodactyly and Möbius anomaly in first cousins: new syndrome or familial facial-limb disruption sequence?

H. Journel; M. Roussey; B. Le Marec


Archives De Pediatrie | 1996

Néphropathie glomérulaire à dépôts mésangiaux d'IgA et maladie de Crohn

A Dabadie; S Gié; S Taque; Jm Babut; M. Roussey


Archives De Pediatrie | 2007

Actualités sur les facteurs de risque et de protection de la mort subite du nourrisson

M. Roussey; Michel Dagorne; G. Defawe; T. Hervé; Martine Balencon; A. Venisse


Archives De Pediatrie | 2004

Capacité de transfert du monoxyde de carbone (TLCO) et saturation artérielle à l'exercice chez les patients atteints de mucoviscidose

L. Chemery; K. Fekete; S. Guillot; M. Roussey; B. Desrues; A. Dabadie; C. Belleguic; E. Deneuville; J. Dassonville

Collaboration


Dive into the M. Roussey's collaboration.

Top Co-Authors

Avatar

Hubert Journel

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C.A. You

University of Rennes

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge